KEYMED BIOSCIENCES -0001 (64Z) — Defensive Interval Ratio
KEYMED BIOSCIENCES -0001 (64Z) has a Defensive Interval Ratio of 664 days as of December 2025. Defensive assets of €1.52 Billion (cash €-, short-term investments €1.42 Billion, receivables €100.85 Million) cover 664 days of daily cash needs of €2.29 Million/day. See how liquid is KEYMED BIOSCIENCES -0001's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
KEYMED BIOSCIENCES -0001 Defensive Interval Ratio (2021–2025)
This chart shows how KEYMED BIOSCIENCES -0001's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 664 days, meaning defensive assets of €1.52 Billion can fund 664 days of operations without new revenue. See KEYMED BIOSCIENCES -0001 (64Z) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for KEYMED BIOSCIENCES -0001 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for KEYMED BIOSCIENCES -0001 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of KEYMED BIOSCIENCES -0001.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 664 days | €1.52 Billion | €2.29 Million/day | €- | €1.42 Billion | ▼ -215 days |
| 2024 | 879 days | €1.80 Billion | €2.05 Million/day | €- | €1.74 Billion | ▼ -1310 days |
| 2023 | 2189 days | €1.88 Billion | €860.77K/day | €- | €1.87 Billion | ▼ -283 days |
| 2022 | 2472 days | €2.57 Billion | €1.04 Million/day | €- | €2.57 Billion | ▼ -4055 days |
| 2021 | 6526 days | €2.00 Billion | €307.05K/day | €- | €2.00 Billion | — |